Welcome to LookChem.com Sign In|Join Free
  • or
C-[(2R,3R,4S,5S,6R)-4-Benzyloxy-6-methoxy-3-(4-methoxy-benzyloxy)-5-triisopropylsilanyloxy-tetrahydro-pyran-2-yl]-methylamine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

468062-68-2

Post Buying Request

468062-68-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

468062-68-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 468062-68-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,6,8,0,6 and 2 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 468062-68:
(8*4)+(7*6)+(6*8)+(5*0)+(4*6)+(3*2)+(2*6)+(1*8)=172
172 % 10 = 2
So 468062-68-2 is a valid CAS Registry Number.

468062-68-2Relevant academic research and scientific papers

Synthesis of novel HIV-1 protease inhibitors based on carbohydrate scaffolds

Murphy, Paul V.,O'Brien, Julie L.,Gorey-Feret, Lorraine J.,Smith III, Amos B.

, p. 2259 - 2271 (2007/10/03)

The synthesis of peptidomimetic inhibitors of HIV-1 protease based on 6-deoxy-6-amino-β-D-glucopyranoside and 6-deoxy-6-amino-β-D-mannopyranoside scaffolds has been achieved. The inhibitors had IC50 values in the micromolar range. The results provide a platform for the development of more potent carbohydrate based inhibitors of HIV-1 and other aspartic proteases.

Structure-based design and synthesis of HIV-1 protease inhibitors employing beta-D-mannopyranoside scaffolds.

Murphy, Paul V,O'Brien, Julie L,Gorey-Feret, Lorraine J,Smith 3rd., Amos B

, p. 1763 - 1766 (2007/10/03)

A preliminary account on the structure-based design, synthesis and evaluation of peptidomimetic inhibitors of HIV-1 protease containing beta-D-mannopyranoside scaffolds is given. The compounds prepared had IC(50) values in the micromolar range. The results provide a platform for the development of more potent carbohydrate-based inhibitors of HIV-1 and other aspartic proteases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 468062-68-2